Article Information
PubMed
Published By
Online ISSN
History
- Received November 25, 2022
- Revision received May 9, 2023
- Accepted May 10, 2023
- Published online May 25, 2023.
Copyright & Usage
© 2023 Ptasinski et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
Author Information
- Victoria Ptasinski1,2,3,4, Conceptualization, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing,
- Susan J Monkley5, Formal analysis, Methodology, Writing—review and editing,
- Karolina Öst1, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—review and editing,
- Markus Tammia5, Formal analysis, Investigation, Visualization, Methodology, Writing—review and editing,
- Hani N Alsafadi2,3,4, Formal analysis, Visualization, Methodology, Writing—review and editing,
- Catherine Overed-Sayer6, Investigation, Methodology, Writing—review and editing,
- Petra Hazon1, Conceptualization, Supervision, Writing—original draft, Project administration, Writing—review and editing,
- Darcy E Wagner2,3,4,*, Conceptualization, Supervision, Funding acquisition, Writing—original draft, Project administration, Writing—review and editing and
- Lynne A Murray6,*, Conceptualization, Supervision, Funding acquisition, Writing—original draft, Project administration, Writing—review and editing⇑
- 1Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
- 2Department of Experimental Medical Sciences, Lung Bioengineering and Regeneration, Lund University, Lund, Sweden
- 3Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden
- 4Lund Stem Cell Center, Lund University, Lund, Sweden
- 5Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
- 6Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
- Correspondence: lynnemurray{at}hotmail.com
Funding
Vetenskapsrådet (VR)
2018-02352DE WagnerKnut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation)
KAW 2020.0182DE WagnerKnut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation)
DE WagnerRegion Skåne
DE Wagner
In this Issue
Advertisement